drugset / Trial / NCT01899677

The Efficacy of Symbiotic on Cytokines

NCT01899677 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this prospective double blinded randomised study is to investigate the efficacy of symbiotic preparation which contains lactobacillus casei, L. rhamnosus, L. plantarum, Bifidobacterium lactis, fructo and galactooligosaccharide on cytokines as interferon-gama acting on Th1 pathway, interleukin -5 acting on Th2, interleukin -10 acting on T regulatory pathway, and interleukin -17 acting on Th-17 pathway that were related with necrotizing enterocolitis pathogenesis in very low birth weight neonates.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-09

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Symbiotic vs Distilled Water; p = 0.32; Mann whitney U NCT01899677 ↗

registry analysis (superiority or other test); Symbiotic vs Distilled Water; p = 0.73; Mann whitney U NCT01899677 ↗

registry analysis (superiority or other test); Symbiotic vs Distilled Water; p = 0.66; Mann whitney U NCT01899677 ↗

registry analysis (superiority or other test); Symbiotic vs Distilled Water; p = 0.76; Mann whitney U NCT01899677 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Symbiotic Unknown 0.5 unknown —